COVIXTA Trademark
Serial Number: 90112582 • Registration: 7082850
COVIXTA is a trademark filed by
Medicago inc.
on August 13, 2020. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Benjamin M. Cantor CANTOR COLBURN LLP
20 CHURCH STREET
FLOOR 22
HARTFORD
CT 06103
Trademark Details
Filing Date
August 13, 2020
Registration Date
June 20, 2023
Published for Opposition
April 4, 2023
Filing History
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 20, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 20, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 4, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2023 CRFA
ASSIGNED TO LIE
Feb 27, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 21, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 25, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 25, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 25, 2022 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 25, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 25, 2022 GNSL
SUSPENSION LETTER WRITTEN
Feb 25, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2022 CRFA
ASSIGNED TO LIE
Feb 24, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 22, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 26, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 26, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 26, 2021 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 18, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 18, 2021 GNSL
SUSPENSION LETTER WRITTEN
Feb 18, 2021 CNSL
ASSIGNED TO EXAMINER
Feb 17, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2020 NWOS
NEW APPLICATION ENTERED
Aug 17, 2020 NWAP